CN101124261A - 酪蛋白衍生肽及其治疗用途 - Google Patents

酪蛋白衍生肽及其治疗用途 Download PDF

Info

Publication number
CN101124261A
CN101124261A CNA2005800140129A CN200580014012A CN101124261A CN 101124261 A CN101124261 A CN 101124261A CN A2005800140129 A CNA2005800140129 A CN A2005800140129A CN 200580014012 A CN200580014012 A CN 200580014012A CN 101124261 A CN101124261 A CN 101124261A
Authority
CN
China
Prior art keywords
peptide
casein
pharmaceutical composition
seq
casein derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800140129A
Other languages
English (en)
Chinese (zh)
Inventor
Z·斯德尔曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptera Pharmaceuticals Ltd
Original Assignee
Peptera Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptera Pharmaceuticals Ltd filed Critical Peptera Pharmaceuticals Ltd
Publication of CN101124261A publication Critical patent/CN101124261A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800140129A 2004-03-01 2005-02-20 酪蛋白衍生肽及其治疗用途 Pending CN101124261A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54840104P 2004-03-01 2004-03-01
US60/548,401 2004-03-01

Publications (1)

Publication Number Publication Date
CN101124261A true CN101124261A (zh) 2008-02-13

Family

ID=34910999

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800140129A Pending CN101124261A (zh) 2004-03-01 2005-02-20 酪蛋白衍生肽及其治疗用途

Country Status (13)

Country Link
US (1) US20070203060A1 (https=)
EP (1) EP1751179A4 (https=)
JP (1) JP2008509073A (https=)
KR (1) KR20070007128A (https=)
CN (1) CN101124261A (https=)
AU (1) AU2005215943A1 (https=)
BR (1) BRPI0507822A (https=)
CA (1) CA2558155A1 (https=)
EA (1) EA200601575A1 (https=)
MX (1) MXPA06010014A (https=)
NO (1) NO20064388L (https=)
WO (1) WO2005081628A2 (https=)
ZA (1) ZA200607735B (https=)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102176918A (zh) * 2008-10-09 2011-09-07 方塔拉合作研究与发展有限公司 痛风的治疗或预防
CN102933223A (zh) * 2010-04-21 2013-02-13 米勒尤迪斯公司 用于治疗子宫感染的酪蛋白肽
WO2014090184A1 (zh) * 2012-12-12 2014-06-19 上海交通大学 一种生物活性多肽qepvl及其制备和应用
WO2014090180A1 (zh) * 2012-12-12 2014-06-19 上海交通大学 一种生物活性多肽qepv及其制备和应用
CN104697830A (zh) * 2015-02-10 2015-06-10 深圳市新产业生物医学工程股份有限公司 用于hiv检测的酸性处理剂、样本预处理方法、试剂盒及检测方法
CN105007760A (zh) * 2013-03-15 2015-10-28 Mjn美国控股有限责任公司 含有肽组分的营养组合物及其用途
CN105072928A (zh) * 2013-03-15 2015-11-18 Mjn美国控股有限责任公司 含有具有抗炎性质的肽组分的营养组合物及其用途
CN107073071A (zh) * 2014-11-06 2017-08-18 Mjn 美国控股有限责任公司 含有肽组分的营养补剂和其用途
CN107176995A (zh) * 2017-07-06 2017-09-19 浙江辉肽生命健康科技有限公司 一种生物活性多肽skvlpvpekavpypq及其制备方法和应用
CN107188949A (zh) * 2017-07-06 2017-09-22 浙江辉肽生命健康科技有限公司 一种生物活性多肽eintvqvtst及其制备方法和应用
CN107814840A (zh) * 2017-12-12 2018-03-20 浙江辉肽生命健康科技有限公司 一种生物活性多肽pkypvepf及其制备方法和应用
CN107827972A (zh) * 2017-12-11 2018-03-23 浙江辉肽生命健康科技有限公司 一种生物活性多肽speviesppein及其制备方法和应用
CN108017709A (zh) * 2017-12-12 2018-05-11 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446A (zh) * 2021-09-03 2022-01-21 河南省医药科学研究院 生物活性肽在抑制骨髓毒性中的应用
CN117567586A (zh) * 2023-10-25 2024-02-20 广州菲勒生物科技有限公司 一种富含唾液酸化肽的水解酪蛋白的制备方法及其在调节肠道菌群中的应用
CN118452475A (zh) * 2024-04-10 2024-08-09 江南大学 一种促钙吸收后生元的制备方法及其应用
CN119119181A (zh) * 2024-09-24 2024-12-13 西北农林科技大学 一种cox2抑制肽、抑制cox2的组合物与应用
CN119320440A (zh) * 2023-07-06 2025-01-17 中国科学院大连化学物理研究所 一种抗菌肽及其应用

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095441A1 (ja) * 2004-03-31 2005-10-13 National Institute Of Advanced Industrial Science And Technology 上皮系細胞増殖促進剤
KR101331777B1 (ko) 2004-12-23 2013-11-21 캄피나 네덜란드 홀딩 베.붸. Ｄｐｐ-ｉｖ를 억제하는 펩타이드가 풍부한 단백질가수분해물 및 이의 용도
EP1851323B1 (en) * 2005-02-24 2016-09-28 DSM IP Assets B.V. Enzymatic process for producing I-P-P from kappa casein
US7968513B2 (en) 2005-05-02 2011-06-28 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
PT2236608T (pt) 2005-10-04 2017-03-01 Soligenix Inc Péptidos novos para tratar e prevenir distúrbios relacionados com a imunidade, incluindo tratar e prevenir infecção por modulação da imunidade inata
WO2007057872A2 (en) * 2005-11-21 2007-05-24 Teagasc-National Diary Products Research Centre Casein-derived antimicrobial peptides and lactobacillus strains that produce them
JP2009517464A (ja) 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
JP2007254449A (ja) * 2006-02-22 2007-10-04 Snow Brand Milk Prod Co Ltd 脂質改善剤
JP5177778B2 (ja) * 2006-02-24 2013-04-10 雪印メグミルク株式会社 ペプチド
GB2436328A (en) * 2006-03-22 2007-09-26 Regen Therapeutics Plc Peptide derived from colostrinin
MX2008013024A (es) * 2006-04-11 2009-04-16 Mileutis Ltd Manejo de ganado para la eficiencia reproductiva mejorada.
AU2007244352B2 (en) * 2006-04-28 2013-09-26 Megmilk Snow Brand Co., Ltd. Peptide
ES2444695T3 (es) 2006-06-23 2014-02-26 Alethia Biotherapeutics Inc. Polinucleótidos y polipéptidos implicados en el cáncer
JP5188731B2 (ja) * 2007-03-02 2013-04-24 雪印メグミルク株式会社 ペプチド
US20110190215A1 (en) * 2008-05-15 2011-08-04 Regen Therapeutics Plc Therapeutic use of peptides
CA2740900C (en) 2008-11-03 2019-09-24 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
DK2370088T3 (en) 2008-12-27 2017-02-20 Pawan Saharan Nanopeptides derived from mammalian colostrum for broad-spectrum viral and recurrent infections and methods for isolation thereof
SG174355A1 (en) 2009-04-03 2011-10-28 Nestec Sa Improvement in promotion of healthy catch-up growth
KR20120027535A (ko) * 2009-06-19 2012-03-21 오럴 헬스 오스트레일리아 피티와이 엘티디 카제인 유래 프로테아제 저해 펩타이드
CA2779161A1 (en) * 2009-10-28 2011-05-05 University Of Manitoba Yellow pea seed protein-derived peptides
JP5479884B2 (ja) * 2009-12-28 2014-04-23 カルピス株式会社 脳機能改善用組成物および脳機能を改善する方法
PT105073A (pt) * 2010-04-26 2011-10-26 Consejo Superior Investigacion Processo de obtenção de extractos peptídicos bioactivos através da hidrólise de proteínas de soro de leite com enzimas de cynara cardunculus, referidos extractos e respectivas utilizações
SI3173427T1 (sl) 2011-03-31 2019-08-30 ADC Therapeutics SA, Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega
US8865155B2 (en) * 2011-09-29 2014-10-21 Centro De Investigacion En Alimentacion Y Desarrollo, A.C. (Ciad) Lactococcus lactis strains, and bacterial preparations thereof, for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects in mammals; nutritional and therapeutic products produced therefrom
KR102102239B1 (ko) 2012-01-09 2020-04-21 에이디씨 테라퓨틱스 에스에이 유방암을 치료하기 위한 방법
WO2013133032A1 (ja) * 2012-03-09 2013-09-12 森永乳業株式会社 ジペプチジルペプチダーゼ－ｉｖ阻害剤
HK1210192A1 (en) 2012-07-19 2016-04-15 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
CN106662578B (zh) 2014-04-03 2021-11-12 艾勒詹尼斯有限责任公司 用于检测食物变态反应的肽、试剂和方法
JP6815994B2 (ja) * 2015-06-22 2021-01-20 株式会社明治 血中ヘモグロビン増加用組成物
CN110381964A (zh) * 2017-03-03 2019-10-25 森永乳业株式会社 Glp-1分泌促进剂和组合物
AU2018332486B2 (en) * 2017-09-15 2022-06-02 Kine Sciences Co., Ltd. Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
CN107903314A (zh) * 2017-11-14 2018-04-13 上海交通大学 一种生物活性多肽eviesppeintv及其制备方法和应用
TWI655203B (zh) * 2017-11-16 2019-04-01 國立中興大學 新穎胜肽、含有該胜肽之組合物及其用途
CN107814835B (zh) * 2017-12-01 2020-04-28 熊猫乳品集团股份有限公司 一种生物活性多肽avpitptlnreq及其制备方法和应用
CN107759682B (zh) * 2017-12-07 2021-03-02 浙江辉肽生命健康科技有限公司 一种生物活性多肽pigsensgkttmpl及其制备方法和应用
CN107814839A (zh) * 2017-12-07 2018-03-20 浙江辉肽生命健康科技有限公司 一种生物活性多肽pigsensekttmpl及其制备方法和应用
CN107880102A (zh) * 2017-12-07 2018-04-06 浙江辉肽生命健康科技有限公司 一种生物活性多肽peviesppein及其制备方法和应用
CN107827971B (zh) * 2017-12-07 2020-04-14 浙江辉肽生命健康科技有限公司 一种生物活性多肽qsltltdve及其制备方法和应用
CN108017703B (zh) * 2017-12-11 2020-07-17 浙江辉肽生命健康科技有限公司 一种生物活性多肽vpitptln及其制备方法和应用
CN107880105B (zh) * 2017-12-11 2020-06-16 浙江辉肽生命健康科技有限公司 一种生物活性多肽vpitptlnr及其制备方法和应用
CN107880106B (zh) * 2017-12-11 2020-06-16 浙江辉肽生命健康科技有限公司 一种生物活性多肽vpitptlnre及其制备方法和应用
CN107880104A (zh) * 2017-12-11 2018-04-06 浙江辉肽生命健康科技有限公司 一种生物活性多肽sppeintvqvt及其制备方法和应用
CN108017708A (zh) * 2017-12-12 2018-05-11 浙江辉肽生命健康科技有限公司 一种生物活性多肽npigsensekttmpl及其制备方法和应用
CN108034002A (zh) * 2017-12-12 2018-05-15 浙江辉肽生命健康科技有限公司 一种生物活性多肽peviesppeintv及其制备方法和应用
CN107880108A (zh) * 2017-12-12 2018-04-06 浙江辉肽生命健康科技有限公司 一种生物活性多肽sfsdipnpigse及其制备方法和应用
KR102073824B1 (ko) * 2018-04-11 2020-02-05 강원대학교산학협력단 간 보호용 건강기능식품 및 이의 제조 방법
WO2023272386A1 (en) * 2021-06-29 2023-01-05 Gill Thomas A Peptides for regulating glucose
CN116333151B (zh) * 2022-08-12 2023-08-25 广西壮族自治区水牛研究所 一种用于检测水牛奶中掺假普通牛乳的单克隆抗体及其制备方法和用途
NL2033588B1 (en) * 2022-11-22 2024-05-30 Univ Ningbo Duck liver protein-derived anti-inflammatory and antimicrobial functional peptide and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
TWI268138B (en) * 2000-05-11 2006-12-11 Kanebo Seiyaku Ltd Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same
CZ2004335A3 (cs) * 2001-08-30 2004-07-14 Chay 13 Medical Research Group N. V. Peptidy odvozené od kaseinu a jejich použití pro léčení

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102176918A (zh) * 2008-10-09 2011-09-07 方塔拉合作研究与发展有限公司 痛风的治疗或预防
CN102933223B (zh) * 2010-04-21 2016-03-09 米勒尤迪斯公司 用于治疗子宫感染的酪蛋白肽
CN102933223A (zh) * 2010-04-21 2013-02-13 米勒尤迪斯公司 用于治疗子宫感染的酪蛋白肽
WO2014090184A1 (zh) * 2012-12-12 2014-06-19 上海交通大学 一种生物活性多肽qepvl及其制备和应用
WO2014090180A1 (zh) * 2012-12-12 2014-06-19 上海交通大学 一种生物活性多肽qepv及其制备和应用
CN105072928A (zh) * 2013-03-15 2015-11-18 Mjn美国控股有限责任公司 含有具有抗炎性质的肽组分的营养组合物及其用途
CN105007760A (zh) * 2013-03-15 2015-10-28 Mjn美国控股有限责任公司 含有肽组分的营养组合物及其用途
CN114041604A (zh) * 2013-03-15 2022-02-15 Mjn 美国控股有限责任公司 含有肽组分的营养组合物及其用途
CN107073071A (zh) * 2014-11-06 2017-08-18 Mjn 美国控股有限责任公司 含有肽组分的营养补剂和其用途
CN104697830A (zh) * 2015-02-10 2015-06-10 深圳市新产业生物医学工程股份有限公司 用于hiv检测的酸性处理剂、样本预处理方法、试剂盒及检测方法
CN107188949B (zh) * 2017-07-06 2019-12-24 浙江辉肽生命健康科技有限公司 一种生物活性多肽eintvqvtst及其制备方法和应用
CN107176995A (zh) * 2017-07-06 2017-09-19 浙江辉肽生命健康科技有限公司 一种生物活性多肽skvlpvpekavpypq及其制备方法和应用
CN107188949A (zh) * 2017-07-06 2017-09-22 浙江辉肽生命健康科技有限公司 一种生物活性多肽eintvqvtst及其制备方法和应用
CN107176995B (zh) * 2017-07-06 2019-12-24 浙江辉肽生命健康科技有限公司 一种生物活性多肽skvlpvpekavpypq及其制备方法和应用
CN107827972A (zh) * 2017-12-11 2018-03-23 浙江辉肽生命健康科技有限公司 一种生物活性多肽speviesppein及其制备方法和应用
CN108017709A (zh) * 2017-12-12 2018-05-11 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
CN107814840A (zh) * 2017-12-12 2018-03-20 浙江辉肽生命健康科技有限公司 一种生物活性多肽pkypvepf及其制备方法和应用
CN113952446A (zh) * 2021-09-03 2022-01-21 河南省医药科学研究院 生物活性肽在抑制骨髓毒性中的应用
CN113952446B (zh) * 2021-09-03 2023-12-05 河南省医药科学研究院 生物活性肽在抑制骨髓毒性中的应用
CN119320440A (zh) * 2023-07-06 2025-01-17 中国科学院大连化学物理研究所 一种抗菌肽及其应用
CN117567586A (zh) * 2023-10-25 2024-02-20 广州菲勒生物科技有限公司 一种富含唾液酸化肽的水解酪蛋白的制备方法及其在调节肠道菌群中的应用
CN118452475A (zh) * 2024-04-10 2024-08-09 江南大学 一种促钙吸收后生元的制备方法及其应用
CN119119181A (zh) * 2024-09-24 2024-12-13 西北农林科技大学 一种cox2抑制肽、抑制cox2的组合物与应用
CN119119181B (zh) * 2024-09-24 2026-01-30 西北农林科技大学 一种cox2抑制肽、抑制cox2的组合物与应用

Also Published As

Publication number Publication date
AU2005215943A1 (en) 2005-09-09
WO2005081628A2 (en) 2005-09-09
EP1751179A4 (en) 2009-03-25
EP1751179A2 (en) 2007-02-14
US20070203060A1 (en) 2007-08-30
BRPI0507822A (pt) 2007-07-10
EA200601575A1 (ru) 2007-06-29
JP2008509073A (ja) 2008-03-27
MXPA06010014A (es) 2007-03-07
WO2005081628A3 (en) 2007-10-18
ZA200607735B (en) 2008-05-28
NO20064388L (no) 2006-11-28
KR20070007128A (ko) 2007-01-12
CA2558155A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
US8735348B2 (en) Casein derived peptides and uses thereof
CN101124261A (zh) 酪蛋白衍生肽及其治疗用途
US7666996B2 (en) Casein derived peptides and uses thereof
WO2015067712A1 (en) Immunosuppressive agents and their use in therapy
CA2458924A1 (en) Casein derived peptides and uses thereof in therapy
US20250170206A1 (en) Composition of bl-8040
US12115207B2 (en) Treatment of inflammation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080213